Is there an association between intestinal perfusion and Crohn's disease activity? A feasibility study using contrast-enhanced ultrasound

British Journal of Radiology

Volumn 82, Issue 974, 2009, Pages 112-117

  Kumar, P ^a   Domjan, J ^a   Bhandari, P ^a   Ellis, R ^a   Higginson, A ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; SONOVUE; BARIUM SULFATE; CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEMODYNAMIC MONITORING; HUMAN; INTESTINE PERFUSION; MALE; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; ULTRASOUND; COMPUTER ASSISTED DIAGNOSIS; ECHOGRAPHY; EPIDEMIOLOGY; INTESTINE MUCOSA; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; SMALL INTESTINE;

ADULT; AGED; BARIUM SULFATE; BLOOD FLOW VELOCITY; CONTRAST MEDIA; CROHN DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; PHOSPHOLIPIDS; SPLANCHNIC CIRCULATION; SULFUR HEXAFLUORIDE; YOUNG ADULT;

EID: 61449228591     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/43430629     Document Type: Article

References (24)

1. Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, et al. Gastroenterology services in the UK. The burden of disease and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 2007;56:1-113.
2. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between the north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996;39:690-7.
3. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122:512-30.
4. Stange EF, Travis SPL, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55:l-15.
5. Van Oostayen JA, Wasser MNJM, van Hogezand RA, Griffioen G, de Roos A. Activity of Crohn's disease assessed by measurement of superior mesenteric artery flow with Doppler US. Radiology 1994;193:551-4.
6. Bolondi L, Gaiani S, Brignola C, Canpieri M, Rigamonti A, Zironi G, et al. Changes in splanchnic haemodynamics in inflammatory bowel disease: non-invasive assessment by Doppler ultrasound flowmetry. Scand J Gastroenterol 1992;27:501-7.
7. Yekeler E, Danalioglu A, Movasseghi B, Yilmas S, Karaca C, Kaymakoglu S, et al. Crohn's disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments. J Ultrasound Med 2005;24:59-65.
8. Ludwig D, Wiener S, Bruning A, Schwarting K, Jantschek G, Stange EF. Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow-up study. Gut. 1999;45:546-52.
9. Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography: contrast studies in anatomy and function. Radiology 1969;92:939-48.
10. Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJK, Cosgroove DO. Advances in ultrasound. Clin Radiol. 2002;57:157-77.
11. Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R, Quigley R. Therapeutic applications of microbubbles. Eur J Radiol 2002;42:160-8.
12. Dijkmans PA, Juffermans LJM, Musters RJP, van Wamel A, ten Cate FJ, van Gilst W, et al. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 2004;5:245-56.
13. Lindner JR. Evolving applications for contrast ultrasound. Am J Cardiol 2002;90:72J-80J.
14. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984;86:249-66.
15. Marshall M, Halligan S, Eckersley RJ, Williams A, Blomley MJ, Cosgrove DO, et al. A novel technique to measure splanchnic transit time using microbubble ultrasound. Investigative Radiology 2005;40:80-4.
16. Fellowes IW, Freeman JG, Holmes GKT. Crohn's disease in the city of Derby, 1951-85. Gut 1990;31:1262-5.
17. Holt S, Samuel E. Grey scale ultrasound in Crohn's disease. Gut 1979;20:590-5.
18. Thoeni RF, Gould RG. Enteroclysis and small bowel series: comparison of radiation dose and examination time. Radiology 1991;20:590-5.
19. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet. 1989;2:1057-62.
20. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
21. Hatoum OA, Binion DG, Gutterman DD. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 2005;35:599-609.
22. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by non-steroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med 1992;152:625-32.
23. Angerson WJ, Allison MC, Baxter JN, Russell RI. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993;34:1531-4.
24. Jarvela IY, Sladkevicius P, Tekay AH, Campbell S, Nargund G. Intraobserver variability of ovarian volume, gray scale and color flow indices obtained using transvaginal threedimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 2003;21:277-82.